Dr. Hector Alonso Mesa Corrales, MD

Dr. Mesa Corrales practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Mesa Corrales' NPI, 1811082209, was assigned on October 3, 2006. Dr. Mesa Corrales holds Maryland license D0101423.

Dr. Mesa Corrales' primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Mesa Corrales' primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Mesa Corrales is also affiliated with University of Maryland Medical Center Midtown Campus. The medical group on file is University of Maryland Pathology Associates, P.A. Dmand AI also links Dr. Mesa Corrales to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mesa Corrales practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology is Dr. Mesa Corrales' primary specialty in the NPI Registry, under taxonomy code 207ZH0000X. Dmand AI has Dr. Mesa Corrales' licenses on file in 2 states: Maryland and Minnesota.

CMS data shows 1,573 Medicare services from Dr. Mesa Corrales across 13 procedure codes in 2024, for 502 Medicare patients. Medicare paid $47,900 for them.

CMS counts 502 Medicare patients who saw Dr. Mesa Corrales in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mesa Corrales' median patient age at 61, with 49% women.

Dr. Mesa Corrales accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Mesa Corrales from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $123.